K562-BCMA/GFP Cell Line

Description: The K562-BCMA/GFP cell line is derived from the K562 chronic myelogenous leukemia (CML) cell line, originally established from a patient in terminal blast crisis. This engineered cell line stably expresses B-cell maturation antigen (BCMA) and green fluorescent protein (GFP). It serves as an ideal target cell for in vitro cytotoxicity assays involving BCMA-targeting therapies.

Quantity: Two vials of frozen cells (2×106 per vial)

Stability: Stable in culture over a minimum of 10 passages

Application: Drug screening, biological assays and in vivo study

Freezing Medium: 70% RPMI 1640 +20% FBS+10% DMSO

Propagation Medium: RPMI1640+10%FBS

Morphology: Lymphoblast

Subculture: Cultures can be maintained by addition or replacement of fresh medium. Start cultures at 2 X 105 cells/mL and maintain between 1 X 105 and 1 X 106 cells/mL.

Incubation: 37 °C with 5% CO2

Storage: Liquid nitrogen immediately upon receiving

Doubling Time: Approximately 40 hours

Mycoplasma Status: Negative

Caution: This product is for research use only and is not intended for therapeutic or diagnostic applications. Please contact a technical service representative for more information.